Agonistic CD40 Therapy Induces Tertiary Lymphoid Structures but Impairs Responses to Checkpoint Blockade in Glioma

Researchers showed that systemic delivery of αCD40 induced hypofunctional T cells and impaired the response to immune checkpoint inhibitors in pre-clinical glioma models.